Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
15.85
+0.17 (1.08%)
At close: Mar 6, 2026, 4:00 PM EST
15.88
+0.03 (0.19%)
After-hours: Mar 6, 2026, 7:05 PM EST
Mesoblast Employees
Mesoblast had 81 employees as of June 30, 2025. The number of employees increased by 8 or 10.96% compared to the previous year.
Employees
81
Change (1Y)
8
Growth (1Y)
10.96%
Revenue / Employee
$807,210
Profits / Employee
-$1,165,062
Market Cap
2.08B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Zai Lab | 1,869 |
| Ultragenyx Pharmaceutical | 1,371 |
| Iovance Biotherapeutics | 975 |
| Ascentage Pharma Group International | 605 |
| Galapagos NV | 558 |
| Soleno Therapeutics | 182 |
| Day One Biopharmaceuticals | 178 |
| Stoke Therapeutics | 128 |
MESO News
- 8 days ago - Mesoblast (MESO) Reports Significant Miss in 1H Earnings - GuruFocus
- 8 days ago - Mesoblast misses H1 estimates - Seeking Alpha
- 8 days ago - Mesoblast Limited (MESO) Q2 2026 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Half Year 2026 Mesoblast Ltd Earnings Presentation Transcript - GuruFocus
- 9 days ago - Ryoncil® Profits Underpinning Substantial Growth Pipeline - GlobeNewsWire
- 10 days ago - What's Next: Mesoblast's Earnings Preview - Benzinga
- 15 days ago - Mesoblast Financial Results and Corporate Update Webcast - GlobeNewsWire
- 23 days ago - Mesoblast Touts High Survival Rates For FDA-Approved Cell Therapy - Benzinga